Assignee
PROXIMAGEN LLC
US11 patents
Top patents by PatentIndex Score
US10590125B2Mar 17, 2020
Compounds
PROXIMAGEN LLC3 citations83
US10428066B2Oct 1, 2019
Imidazo[4,5-C]pyridine and pyrrolo[2,3-C]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC6 citations83
US11512082B2Nov 29, 2022
Substituted imidazo[4,5-c]pyridine compounds and compositions thereof
PROXIMAGEN LLC1 citations72
US10968223B2Apr 6, 2021
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC1 citations72
US10766897B2Sep 8, 2020
Imidazo[4,5-c]pyridine and pyrrolo[2,3-c]pyridine derivatives as SSAO inhibitors
PROXIMAGEN LLC1 citations72
US10995091B2May 4, 2021
CXCR4 receptor antagonists
PROXIMAGEN LLC3 citations70
US10155761B2Dec 18, 2018
CXCR4 receptor antagonists
PROXIMAGEN LLC4 citations70
US11530208B2Dec 20, 2022
Imidazo[4,5-C]pyridine derived SSAO inhibitors
PROXIMAGEN LLC1 citations62
US11369616B2Jun 28, 2022
Drug combination and its use in therapy
PROXIMAGEN LLC0 citations62
US11311552B2Apr 26, 2022
Therapies for cancer
PROXIMAGEN LLC0 citations53
US10738044B2Aug 11, 2020
Therapeutic compound and use in therapy
PROXIMAGEN LLC0 citations51